Stand: April 2021

• Jasper Iske, Midas Seyda, Timm Heinbokel, Ryoichi Maenosono, Koichiro Minami, Yeqi Nian, Markus Quante, Christine S. Falk, Haruhito Azuma, Friederike Martin, João F. Passos, Claus U. Niemann, Tamara Tchkonia, James L. Kirkland , Abdallah Elkhal & Stefan G. Tullius. Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantation. Nat Commun. 2020; 11(1):4289.
• Thierry Siemeni, Ann-Kathrin Knöfel, Fabio Ius, Wiebke Sommer, Jawad Salman, Dietmar Böthig, Christine S Falk, Igor Tudorache, Axel Haverich, Gregor Warnecke. Transplant arteriosclerosis in humanized mice reflects chronic lung allograft dysfunction and is controlled by regulatory T cells. J Thorac Cardiovasc Surg. 2019; 157(6):2528-2537.
• Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med 2020; 383(2):120-128.
• Ricarda Blöte, Nima Memaran, Bianca Borchert-Mörlins, Daniela Thurn-Valsassina, Imeke Goldschmidt, Rita Beier, Martin Sauer, Carsten Müller, Giselle Sarganas, Jun Oh, Rainer Büscher, Markus J. Kemper, Rizky I. Sugianto, Jelena Epping, Bernhard M.W. Schmidt, and Anette Melk. Greater Susceptibility for Metabolic Syndrome in Pediatric Solid Organ and Stem Cell Transplant Recipients. Transplantation. 2019; 103(11):2423-2433.
• F. Noyan†, K. Zimmermann†, M. Hardtke-Wolenski, A. Knoefel, E. Schulde, R. Geffers, M. Hust, J. Huehn, M. Galla, M. Morgan, A. Jokuszies, M. P. Manns and E. Jaeckel. Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC-Specific Chimeric Antigen Receptor. Am J Transpl. 2016; 22(7):943-955.
• Marcel Maluski, Arnab Ghosh, Jessica Herbst, Vanessa Scholl, Rolf Baumann, Jochen Huehn, Robert Geffers, Johann Meyer, Holger Maul, Britta Eiz-Vesper, Andreas Krueger, Axel Schambach, Marcel R.M. van den Brink, and Martin G. Sauer. Chimeric antigen receptor–induced BCL11B suppression propagates NK-like cell development. J Clin Invest. 2019; 129(12):5108-5122.
• Constança Figueiredo, Felix Oldhafer, Eva‐Maria Wittauer, Marco Carvalho‐Oliveira, Ali Akhdar, Oliver Beetz, Chen Chen‐Wacker, Yuliia Yuzefovych, Christine S. Falk, Rainer Blasczyk, Florian W.R. Vondran. Silencing of HLA class I on primary human hepatocytes as a novel strategy for reduction in alloreactivity. J Cell Mol Med. 2019; 23(8):5705-5714.
• Gabriel Loor, Gregor Warnecke, Mauricio A Villavicencio, Michael A Smith, Jasleen Kukreja, Abbas Ardehali, Matthew Hartwig, Mani A Daneshmand, Marshall I Hertz, Stephen Huddleston, Axel Haverich, Joren C Madsen, Dirk Van Raemdonck. Portable normothermic ex-vivo lung perfusion, ventilation, and functional assessment with the Organ Care System on donor lung use for transplantation from extended-criteria donors (EXPAND): a single-arm, pivotal trial. Lancet Respir Med. 2019; 7(11):975-984.
• Wiebke Sommer, Jawad Salman, Murat Avsar, Klaus Hoeffler, Katharina Jansson, Thierry N. Siemeni, Ann‐Kathrin Knoefel, Linda Ahrens, Reza Poyanmehr, Igor Tudorache, Peter Braubach, Danny Jonigk, Axel Haverich, Gregor Warnecke. Prediction of transplant outcome after 24-hour ex vivo lung treatment of early donor-specific antibodies with IgA- and IgM-enriched intravenous human immunoglobulins in lung transplantation. Am J Transplant. 2019; 19(2):345-355.
• Gregor Warnecke, Dirk Van Raemdonck, Michael A Smith, Gilbert Massard, Jasleen Kukreja, Federico Rea, Gabriel Loor, Fabio De Robertis, Jayan Nagendran, Kumud K Dhital, Francisco Javier Moradiellos Díez, Christoph Knosalla, Christian A Bermudez, Steven Tsui, Kenneth McCurry, I-Wen Wang, Tobias Deuse, Guy Lesèche, Pascal Thomas, Igor Tudorache, Christian Kühn, Murat Avsar, Bettina Wiegmann, Wiebke Sommer, Arne Neyrinck, Marco Schiavon, Fiorella Calabrese, Nichola Santelmo, Anne Olland, Pierre-Emanuel Falcoz, Andre R Simon, Andres Varela, Joren C Madsen, Marshall Hertz, Axel Haverich, Abbas Ardehali. Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomized, open-label, non-inferiority, phase 3 study. Lancet Respir Med. 2018; 6(6):e27.

• Becher PM, et al. Clinical characteristics and outcomes of patients with adult congenital heart disease listed for heart and heartlung transplantation in the Eurotransplant region. J.Heart Lung Transplant. 2020.
• Beetz O, et al. Abdominal Surgery in Patients with Ventricular Assist Devices: a Single-Center Report . ASAIO J. 2020.
• Hanke JS, et al. First-in-man explantation of a HeartMate 3 left ventricular assist device via customized plug. Eur.J.Cardiothorac.Surg. 2020.
• Ius F, et al. Heart Preservation with the Organ Care System in Extended Criteria Donors: A Single-Center Experience. Thorac.Cardiovasc.Surg. 2020.
• Ius F, et al. Heart Preservation with the Organ Care System in Extended Criteria Donor Hearts: A Three-Center Experience. J Heart Lung Transplant,.2020.
• Ius F, et al.  Treatment of Anti-HLA Donor-Specific Antibodies in Heart Transplantation: A Single-Center Experience. J Heart Lung Transplant. 2020.
• Kühne JF, et al. In Combined Heart/Lung Transplantation, the Reperfusion Response in Recipients is Dominated by Heart-Associated Cytokine and Endothelial Patterns While the Ischemic Injury in the Storage Solution is Dominated by a Lung-Associated Microenvironment. J Heart Lung Transplant. 2020.
• Mogaldea A, et al. Upper-body cannulation for midterm mechanical circulatory support: A novel bridging strategy to cardiac retransplantation. Int.J.Artif.Organs. 2020.
• Rojas SV, et al. Ex vivo Heart Perfusion for Heart Transplantation: A Single-Center Update after 5 Years. Thorac.Cardiovasc.Surg. 2020.
• Rojas SV, et al. Ex Vivo Organ Perfusion for Heart Procurement in High-Risk Transplantations: A Multicenter Study. J Heart Lung Transplant, 2020.
• Sponga S, et al. Normothermic Ex-Vivo Perfusion for Donor Heart Preservation in Transplantation of Patients Bridged with Ventricular Assist Devices. J Heart Lung Transplant. 2020.
• Walter C, et al. Infrastructural needs and expected benefits of telemonitoring in left ventricular assist device therapy: Results of a qualitative study using expert interviews and focus group discussions with patients. Int.J.Artif.Organs. 2020.
• Weigle CA, et al. An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats. J.Vis.Exp., 2020.
• Zimpfer D, et al. Long-Term Survival of Patients With Advanced Heart Failure Receiving an Left Ventricular Assist Device Intended as a Bridge to Transplantation: The Registry to Evaluate the HeartWare Left Ventricular Assist System. Circ.Heart Fail. 2020.

• Berenguer M, et al. Characteristics, trends and Outcomes of Liver Transplantation for Primary sclerosing cholangitis in female vs male patients: An analysis from the European Liver Transplant Registry. Transplantation. 2020.
• Busch M et Wedemeyer HH. Akutes Leberversagen - die Bedeutung einer schnellen Diagnostik und frühen Therapieeinleitung. Internist (Berl). 2020.
• Engel B, et al. The future of autoimmune liver diseases - Understanding pathogenesis and improving morbidity and mortality. Liver Int. 2020.
• Engelmann C, et al. Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers . J.Clin.Med. 2020.
• Germani G, et al. Influence of donor and recipient gender on liver transplantation outcomes in Europe. Liver Int. 2020.
• Höfer A, et al. Non-invasive screening for subclinical liver graft injury in adults via donor-specific anti-HLA antibodies. Sci.Rep. 2020.
• Mederacke YS, et al. T cell receptor repertoires within liver allografts are different to those in the peripheral blood. J.Hepatol. 2020.
• Memaran N, et al.Prospective assessment of subclinical cardiovascular damage and associated factors in liver transplant recipients. Transpl.Int. 2020.
• Pflugrad H, et al.Brain function and metabolism in patients with long-term tacrolimus therapy after kidney transplantation in comparison to patients after liver transplantation. PLoS One. 2020.
• Rashidi-Alavijeh J, et al. Primary sclerosing cholangitis as an independent risk factor for cytomegalovirus infection after liver transplant. Transpl.Infect.Dis. 2020.
• Rashidi-Alavijeh J, et al. Safety and efficacy of tenofovir alafenamide in liver transplant recipients: a single center experience. Transpl.Infect.Dis. 2020.
• Schnitzbauer AA, et al. mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors. Ann.Surg. 2020.
• Waldron LS, et al. Diaphragmatic Hernia following Pediatric Liver Transplantation: An Underappreciated Complication Prone to Recur Eur J Pediatr Surg. 2020.
• Willuweit K, et al. HLA class II donor specific antibodies are associated with graft cirrhosis after liver transplant independent of the mean fluorescence intensity level. BMC Gastroenterol. 2020. 

• Arens J, et al. Toward a Long-Term Artificial Lung. ASAIO J.. 2020.
• Bellmàs Sanz R, et al. Donor T and NK Cells with a Special Tissue-Resident Memory Phenotype Migrate into the Periphery of Lung Transplant Recipients - A Potential Feature for Tolerance Development. J Heart Lung Transplant. 2020.
• Derlin K, et al.Application of MR diffusion imaging for non-invasive assessment of acute kidney injury after lung transplantation. Medicine (Baltimore). 2020.
• Greer M et Welte T. Chronic Obstructive Pulmonary Disease and Lung Transplantation. Semin.Respir.Crit.Care.Med. 2020.
• Hacker KS, et al.Delayed non-myeloablative irradiation to induce long-term allograft acceptance in a large animal lung transplantation model. Transpl.Immunol. 2020.
• Hitz A, et al. Lung Transplant Recipients Developing Early DSA within the First Month are Characterized by a Higher Frequency of Naïve and a Lower Frequency of Memory B Cells. J Heart Lung Transplant. 2020.
• Ius F, et al. Long-term outcomes after intraoperative extracorporeal membrane oxygenation during lung transplantation. J.Heart Lung Transplant. 2020.
• Ius F, et al. Impact of Unilateral Diaphragmatic Dysfunction on Postoperative Outcome after Bilateral Lung Transplantation. Thorac.Cardiovasc.Surg. 2020.
• Ius F, et al. Six-year experience with treatment of early donor-specific anti-HLA antibodies in pediatric lung transplantation using a human immunoglobulin-based protocol. Pediatr.Pulmonol. 2020.
• Ius F, et al. Increased Frequency of Regulatory CD127low T Cells Early after Lung Transplant is Associated with Improved Graft Survival: 10-Year Single-Center Experience. J Heart Lung Transplant. 2020.
• Ius F, et al. Increased frequency of CD4(+) CD25(high) CD127(low) T cells early after lung transplant is associated with improved graft survival - a retrospective study. Transpl.Int. 2020.
• Ius F, et al. Membrane Oxygenation during Lung Transplantation and Long-Term Graft Function: Results from a 9-Year Single-Center Experience. J Heart Lung Transplant. 2020.
• Ius F, et al. Six-Year Clinical Results of an IgA-and IgM-Enriched Human Immunoglobulin-Based Therapy for Early Anti-HLA Donor Specific Antibodies after Lung Transplantation. Thorac.Cardiovasc.Surg. 2020.
• Ius F, et al. Six-Year Results of an IgA- and IgM-Enriched Immunoglobulin-Based Therapy for Early Detectable Anti-HLA Donor Specific Antibodies in Lung Transplantation. J Heart Lung Transplant. 2020.
• Janciauskiene S, et al. Plasma Acute Phase Proteins as Predictors of Chronic Lung Allograft Dysfunction in Lung Transplant Recipients. J.Inflamm.Res. 2020.
• Möhre M, et al. Factor Analyses and Validity of the Transplant Evaluation Rating Scale (TERS) in a Large Sample of Lung Transplant Candidates. Front.Psychiatry. 2020.
• Salman J, et al. Intraoperative Extracorporeal Circulatory Support in Lung Transplantation for Pulmonary Fibrosis. Ann.Thorac.Surg. 2020.
• Siemeni T, et al. Correlation of CLAD in Lung Transplant Recipients with Transplant Arteriosclerosis in Humanized Mice: A 5-years Follow Up Analysis. J Heart Lung Transplant. 2020.
• Werlein C, et al. Lung Transplant Pathology: An Overview on Current Entities and Procedures. Surg.Pathol.Clin. 2020.

• Ahlenstiel-Grunow T, et al. BK Polyomavirus-specific T Cells as a Diagnostic and Prognostic Marker for BK Polyomavirus Infections After Pediatric Kidney Transplantation. Transplantation 2020.
• Ahlenstiel-Grunow T, et al. Steering Transplant Immunosuppression by Measuring Virus-Specific T Cell Levels: The Randomized, Controlled IVIST Trial. J.Am.Soc.Nephrol. 2020.
• Ahlenstiel-Grunow T, et al. Virus-specific T cells in pediatric renal transplantation. Pediatr.Nephrol. 2020.
• Beetz O, et al. Surgical complications in pediatric kidney transplantation -Incidence, risk factors, and effects on graft survival: A retrospective single-center study. Pediatr.Transplant. 2020.
• Bünemann M, et al. Beliefs about immunosuppressant medication and correlates in a German kidney transplant population. J.Psychosom.Res. 2020.
• Callemeyn J, et al. Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific Antibodies. J.Am.Soc.Nephrol. 2020.
• de Boer S, et al. Knowledge About Immunosuppressant Medication and Its Correlates in a German Kidney Transplant Population - Results of a KTx360 degrees Substudy. Patient Prefer Adherence. 2020.
• Einecke G, et al. Factors associated with kidney graft survival in pure antibody-mediated rejection at the time of indication biopsy: Importance of parenchymal injury but not disease activity. Am.J.Transplant. 2020.
• Feddersen N, et al. Adherence in pediatric renal recipients and its effect on graft outcome, a single-center, retrospective study. Pediatr.Transplant. 2020.
• Francis A, et al. Survival after Kidney Transplantation during Childhood and Adolescence. Clin.J.Am.Soc.Nephrol. 2020.
• Halloran PF, et al. Discovering novel injury features in kidney transplant biopsies associated with TCMR and donor aging. Am.J.Transplant. 2020.
• Hanke AA, et al. Influence of Officially Ordered Restrictions During the First Wave of COVID-19 Pandemic on Physical Activity and Quality of Life in Patients after Kidney Transplantation in a Telemedicine Based Aftercare Program-A KTx360 degrees Sub Study. Int.J.Environ.Res.Public.Health. 2020.
• Hauser IA, et al. Effect of everolimus-based drug regimens on CMV-specific T-cell functionality after renal transplantation: 12-month ATHENA subcohort-study results. Eur.J.Immunol. 2020.
• Kanzelmeyer NK, et al. The role of protocol biopsies after pediatric kidney transplantation. Medicine (Baltimore). 2020.
• Kreimann K, et al. Ischemia Reperfusion Injury Triggers CXCL13 Release and B-Cell Recruitment After Allogenic Kidney Transplantation. Front.Immunol. 2020.
• Kühne JF, et al. Differential effects of Belatacept on virus-specific memory versus de novo allo-specific T cell responses of kidney transplant recipients and healthy donors. Transpl.Immunol. 2020.
• Madill-Thomsen K, et al. Discrepancy analysis comparing molecular and histology diagnoses in kidney transplant biopsies. Am.J.Transplant. 2020.
• Mazhari AL, et al. Die Versorgung von Patienten nach Nierentransplantation außerhalb der Regelversorgung: Herausforderungen und Chancen für die Nachsorge von Patienten im Projekt NTx360°. Nieren Hochdruck. 2020.
• Mehrabi A, et al. Consensus on definition and severity grading of lymphatic complications after kidney transplantation. Br.J.Surg. 2020.
• Melk A, et al. Sex disparities in dialysis initiation, access to waitlist, transplantation and transplant outcome in German patients with renal disease-A population based analysis. PLoS One. 2020.
• Mertens I, et al. Urinary Protein Biomarker Panel for the Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Recipients Kidney. Int.Rep. 2020.
• Naik MG, et al. Determinants of Successful Use of Sirolimus in Renal Transplant Patients. Transplant.Proc. 2020.
• Nöhre M, et al. Obesity After Kidney Transplantation-Results of a KTx360 degrees Substudy. Front.Psychiatry. 2020.
• Pape L, et al. NTx360° - ein klinik- und sektorenübergreifendes koordiniertes, multimodales, telemedizinbasiertes Nachsorgemodell nach Nierentransplantation. Springer Gabler. 2020.
• Patecki M, et al. Long-term renal graft outcome after parathyroidectomy - a retrospective single centre study. BMC Nephrol. 2020.
• Pflugrad H, et al. Brain function and metabolism in patients with long-term tacrolimus therapy after kidney transplantation in comparison to patients after liver transplantation. PLoS One. 2020.
• Stocklassa T, et al.Sex Differences in Subclinical Cardiovascular Organ Damage After Renal Transplantation: A Single-Center Cohort Study J.Womens Health.(Larchmt) 2020.
• Süsal C, et al. Should kidney allografts from old donors be allocated only to old recipients? Transpl.Int. 2020.
• Tinel C, et al. Development and validation of an optimized integrative model using urinary chemokines for noninvasive diagnosis of acute allograft rejection. Am.J.Transplant. 2020.
• Yepes-Calderon M, et al. Post-transplantation plasma malondialdehyde is associated with cardiovascular mortality in renal transplant recipients: a prospective cohort study. Nephrol.Dial.Transplant. 2020.
• Yuzefovych Y, et al. Genetic Engineering of the Kidney to Permanently Silence MHC Transcripts During ex vivo Organ Perfusion Front.Immunol. 2020.

Transplantation

• Iske J, et al. Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantation. Nat Commun. 2020.
• Becker F, et al. Optimizing Organ Donation: Expert Opinion from Austria, Germany, Spain and the U.K. Ann.Transplant. 2020.
• Dona D, et al. Pediatric transplantation in Europe during the COVID-19 pandemic: Early impact on activity and healthcare. Clin.Transplant. 2020.
• Kummer L, et al. Vascular Signaling in Allogenic Solid Organ Transplantation - The Role of Endothelial Cells- Front.Physiol. 2020.
• Laws HJ, et al. Impfen bei Immundefizienz : Anwendungshinweise zu den von der Standigen Impfkommission empfohlenen Impfungen. (III) Impfen bei hamatologischen und onkologischen Erkrankungen (antineoplastische Therapie, Stammzell transplantation), Organtransplantation und Asplenie. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020.
• Mund E, et al. Clinically latent and autopsy-verified inflammatory disorders and malignant tumours in transplant patients. J.Clin.Pathol. 2020.
• Oedingen C, et al. Public preferences for the allocation of donor organs for transplantation: Focus group discussions. Health Expect. 2020.
• Qu Z, et al. Organ procurement and transplantation in Germany during the COVID-19 pandemic. Lancet. 2020.
• Timrott K, et al. The importance of MHC class II in allogeneic bone marrow transplantation  and chimerism-based solid organ tolerance in a rat model.LoS One. 2020.

Review Artikel

• Bartling T, et al. A systematic review of physicians' and patients' preferences regarding the allocation of deceased donor organs: to what extent are physicians acting as advocates for their patients? Transplantation. 2020.
• Calabrese F, et al. Organ Care System Lung resulted in lower apoptosis and iNOS expression in donor lungs. Am.J.Transplant. 2020.
• Oedingen C, et al. Systematic review and focus group discussions of public preferences for the allocation deceased donor organs as preliminary works: building a dicrete choice experiment evaluating principles of distributive justice. Transplantation. 2020.

• Barten M, et al. Comparing everolimus-based immunosuppression with reduction or withdrawal of calcineurin inhibitor reduction from six months after heart transplantation: the randomized MANDELA study. Am.J.Transplant., 2019.
• Beetz O, et al. Recipient natural killer cells alter the course of rejection of allogeneic heart grafts in rats. PLoS One. 2019.
• Figueiredo C, et al.Low immunogenic endothelial cells endothelialize the Left Ventricular Assist Device. Sci.Rep. 2019.
• Hohmann S, et al. Initial experience with telemonitoring in left ventricular assist device patients. J.Thorac.Dis. 2019.
• Ius F, et al. Cardiac Transplantation across Preformed HLA-Antibody Barriers: Results of a Peritransplant Desensitization Protocol. J Heart Lung Transplant. 2019.
• Latus H, et al. Reduced Biventricular Volumes and Myocardial Dysfunction Long-term After Pediatric Heart Transplantation Assessed by CMR. Transplantation. 2019.
• Mariani S, et al. Is this the right MOMENTUM?-evidence from a HeartMate 3 randomized trial. J.Thorac.Dis. 2019.
• Przybylek B, et al. Novel Cytokine Score and Cardiac Allograft Vasculopathy. Am J Cardiol. 2019.
• Uribarri A, et al. Prognostic Value of the Nutritional Risk Index in Candidates for Continuous Flow Left Ventricular Assist Device Therapy. Rev.Esp.Cardiol.(Engl.Ed) 2019.
• Uriel N, et al. Echocardiographic Changes in Patients Implanted with a Fully Magnetically Levitated Left Ventricular Assist Device (HeartMate 3). J.Card.Fail. 2019.

• Adam R, et al. Improved Survival in Liver Transplant Patients Receiving Prolonged-release Tacrolimus-based Immunosuppression in the European Liver Transplant Registry (ELTR): An Extension Study. Transplantation. 2019.
• Dirks M, et al. Impact of immunosuppressive therapy on brain derived cytokines after liver transplantation. Transpl Immunol. 2019.
• Fischler B, et al. Similarities and Differences in Allocation Policies for Pediatric Liver Transplantation Across the World J.Pediatr.Gastroenterol.Nutr. 2019.
• Goede LL, et al. Quantitative magnetic resonance imaging indicates brain tissue alterations in patients after liver transplantation. PLoS One. 2019.
• Harms MH, et al. Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades. Aliment Pharmacol Ther. 2019.
• Harries L, et al. Potential savings in the treatment pathway of liver transplantation: an inter-sectorial analysis of cost-rising factors. Eur J Health Econ. 2019.
• Höfer A, et al. DSA are associated with more graft injury, more fibrosis and upregulation of rejection associated transcripts in subclinical rejection. Transplantation. 2019.
• Hopp AE, et al. Hepatic Encephalopathy Is Reversible in the Long Term After Liver Transplantation. Liver Transpl. 2019.
• Kornerup L, et al. Cognitive impairment after liver transplantation: residual hepatic encephalopathy or posttransplant encephalopathy? Hepat Med. 2019.
• Mayer K, et al. Psychosocial outcome and resilience after paediatric liver transplantation in young adults. Clin.Res.Hepatol.Gastroenterol. 2019.
• Memaran N, et al. High Burden of Subclinical Cardiovascular Target Organ Damage After Pediatric Liver Transplantation. Liver Transpl. 2019.
• Möhring T, et al. Immune Status in Children Before Liver Transplantation-A Cross-Sectional Analysis Within the ChilsSFree Multicentre Cohort Study. Front Immunol. 2019.
• Pflugrad H, et al. Cerebral metabolite alterations in patients with posttransplant encephalopathy after liver transplantation. PLoS One. 2019.
• Sandmann L, et al. Treatment strategies for patients with decompensated liver cirrhosis due to hepatitis C virus infection eligible for liver transplantation: real-life data from five German transplant centers. Eur J Gastroenterol Hepatol. 2019.
• Schmitz B, et al. Brain metabolic alterations in patients with long-term calcineurin inhibitor therapy after liver transplantation. Aliment Pharmacol Ther. 2019.
• Trunečka P, et al. The Effect of Donor Age and Recipient Characteristics on Renal Outcomes in Patients Receiving Prolonged-Release Tacrolimus After Liver Transplantation: Post-Hoc Analyses of the DIAMOND Study. Ann Transplant. 2019.

• Beetz O, et al. A Case of Recurrent Pneumoperitoneum and Pneumatosis Intestinalis After Bilateral Lung Transplant. Exp Clin Transplant. 2019.
• Bertram A, et al. Adherence is associated with a favorable outcome after lung transplantation. PLoS One. 2019.
• Figueiredo C, et al. Immunoengineering of the Vascular Endothelium to Silence MHC Expression During Normothermic Ex Vivo Lung Perfusion. Hum Gene Ther. 2019.
• Glanville A, et al. Chronic lung allograft dysfunction: Definition and update of restrictive allograft syndrome-A consensus report from the Pulmonary Council of the ISHLT. J.Heart Lung Transplant. 2019.
• Gottlieb J, et al. A randomized trial of everolimus-based quadruple therapy vs standard triple therapy early after lung transplantation. Am.J.Transplant. 2019.
• Gräger N, et al. Risk Factors for Developing Nonmelanoma Skin Cancer after Lung Transplantation. J.Skin Cancer. 2019
• Ius F, et al. Five-Year Results of an IgA and IgM-Enriched Human Immunoglobulin G-Based Therapy for Early Anti-HLA Donor Specific Antibodies in 158 Lung-Transplanted Patients. J Heart Lung Transplant. 2019.
• Ius F, et al. Increased Frequency Of regulatory CD127low T Cells and of IL2+ T Cells Early after Lung Transplant is Associated with Improved Graft Survival. J Heart Lung Transplant. 2019.
• Ius F, et al. Five-Year Experience with Treatment of Early Donor Specific Anti-HLA Antibodies in Pediatric Lung Transplant Recipients. J Heart Lung Transplant. 2019.
• Kordes A, et al. Genetically diverse Pseudomonas aeruginosa populations display similar transcriptomic profiles in a cystic fibrosis explanted lung. Nat Commun. 2019.
• Law N, et al. Lack of association of Aspergillus colonization with the development of bronchiolitis obliterans syndrome in lung transplant recipients: An international cohort study. J.Heart Lung Transplant. 2019.
• Loor G, et al. Portable normothermic ex-vivo lung perfusion, ventilation, and functional assessment with the Organ Care System on donor lung use for transplantation from extended-criteria donors (EXPAND): a single-arm, pivotal trial. Lancet Respir Med. 2019.
• Moher Alsady T, et al. MRI-derived regional flow-volume loop parameters detect early-stage chronic lung allograft dysfunction. J.Magn.Reson.Imaging. 2019.
• Nöhre M, et al. Psychometric Properties of the German Version of the Pulmonary-Specific Quality-of-Life Scale in Lung Transplant Patients. Front.Psychiatry. 2019.
• Renne J, et al. Functional Pulmonary Magnetic Resonance Imaging for Detection of Ischemic Injury in a Porcine Ex-Vivo Lung Perfusion System Prior to Transplantation. Acad Radiol. 2019.
• Salman J, et al. Long-Term Results of Bilateral Lung Transplantation in Patients With End-Stage Pulmonary Lymphangioleiomyomatosis. Prog Transplant. 2019.
• Seeliger B, et al. Risk factors and outcomes of vocal cord paralysis after lung transplantation - a retrospective cohort study. Transpl Int. 2019.
• Siemeni T, et al. Transplant arteriosclerosis in humanized mice reflects chronic lung allograft dysfunction and is controlled by regulatory T cells. J Thorac Cardiovasc Surg. 2019.
• Sommer W, et al. Extended criteria donor lungs do not impact recipient outcomes in pediatric transplantation. J Heart Lung Transplant. 2019.
• Sommer W, et al. Prediction of transplant outcome after 24-hour ex vivo lung perfusion using the Organ Care System in a porcine lung transplantation model. Am J Transplant. 2019.
• Sommer W, et al. Transplantation of donor lungs with pulmonary embolism - a retrospective study. Transpl Int. 2019.
• Verleden G, et al. Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT. J.Heart Lung Transplant. 2019.
• Welte T, et al. Invasive mould infections in solid organ transplant patients: modifiers and indicators of disease and treatment response. Infection. 2019.
• Welte T, et al. Ten tips for the intensive care management of transplanted lung patients. Intensive Care Med. 2019.
• Wohlschlaeger J, et al. Lungentransplantation : Histomorphologische Diagnostik und klinische Aspekte. Pathologe. 2019.

• Abeling T, et al. Risk factors for death in kidney transplant patients: analysis from a large protocol biopsy registry. Nephrol Dial Transplant. 2019.
• Balzer MS, et al. Pre-transplant dialysis modality and long-term patient and kidney allograft outcome: A 15-year retrospective single center cohort study. Transpl Int. 2019.
• Borsum N, et al. Cytokine Profiles in Children After Pediatric Kidney Transplantation With Acute Cellular Compared to Chronic Antibody-mediated Rejection and Stable Patients: A Pilot Study. Transplant.Direct. 2019.
• Brakemeyer S, et al. Everolimus in de novo kidney transplant recipients participating in the Eurotransplant senior program: Results of a prospective randomized multicenter study (SENATOR).PLoS One. 2019.
• Chatzikyrkou C, et al. Predictors of Outcomes of Living Kidney Donation: Impact of Sex, Age and Preexistent Hypertension. Transplant Proc. 2019.
• Egelkamp J, et al. Back signaling of HLA class I molecules and T/NK cell receptor ligands in epithelial cells reflects the rejection-specific microenvironment in renal allograft biopsies. Am J Transplant. 2019.
• Haffner G, et al. CKD-MBD post kidney transplantation. Pediatr.Nephrol. 2019.
• Hanff E, et al. Development and validation of GC-MS methods for the comprehensive analysis of amino acids in plasma and urine and applications to the HELLP syndrome and pediatric kidney transplantation: evidence of altered methylation, transamidination, and arginase activity. Amino Acids. 2019.
• Hruba P, et al. Molecular Patterns Discriminate Accommodation and Subclinical Antibody-mediated Rejection in Kidney Transplantation. Transplantation. 2019.
• Kettler B, et al. Kidney graft survival of >25 years: A single center report including associated graft biopsy results. Transpl Int. 2019.
• Klewitz F, et al. Information Needs of Patients About Immunosuppressive Medication in a German Kidney Transplant Sample: Prevalence and Correlates. Front.Psychiatry. 2019.
• Lieb M, et al. Subjektiver Gesundheitszustand von Lebendnierenspendern und psychosoziale Korrelate. Nieren Hochdruck. 2019.
• Madill-Thompson K, et al. Discrepancy analysis comparing molecular and histology diagnoses in kidney transplant biopsies. Am.J.Transplant. 2019.
• Marx D, et al. Proteomics in Kidney Allograft Transplantation-Application of Molecular Pathway Analysis for Kidney Allograft Disease Phenotypic Biomarker Selection. Proteomics Clin.Appl. 2019.
• Mederacke YS, et al. Transient increase of activated regulatory T cells early after kidney transplantation. Sci Rep. 2019.
• Nöhre M, et al. Prevalence and Correlates of Cognitive Impairment in Kidney Transplant Patients Using the DemTect-Results of a KTx360 Substudy. Front.Psychiatry. 2019.
• Scheel J, et al. Psychological processing of a kidney transplantation, perceived quality of life, and immunosuppressant medication adherence. Patient Prefer Adherence. 2019 .
• Scheffner I, et al. Patient survival after kidney transplantation: important role of graft-sustaining factors as determined by predictive modeling using random survival forest analysis. Transplantation. 2019.
• Schiffer L, et al. Challenges in Long-Term Follow-Up Care of Patients After Kidney Transplantation in Specialized Transplant Centers. Gesundheitswesen. 2019.
• Schiffer L, et al. Chemokine CXCL13 as a New Systemic Biomarker for B-Cell Involvement in Acute T Cell-Mediated Kidney Allograft Rejection. Int J Mol Sci. 2019.
• Schwager Y, et al. Prediction of Three-Year Mortality After Deceased Donor Kidney Transplantation in Adults with Pre-Transplant Donor and Recipient Variables. Ann Transplant. 2019.
• Tkachenko D, et al. Dyadic Coping of Kidney Transplant Recipients and Their Partners: Sex and Role Differences. Front.Psychol. 2019.
• Van Alem C, et al. Liposomal delivery improves the efficacy of prednisolone to attenuate renal inflammation in a mouse model of acute renal allograft rejection. Transplantation. 2019.
• Van Loon, et al. Development and validation of a peripheral blood mRNA assay for the assessment of antibody-mediated kidney allograft rejection: A multicentre, prospective study. EBioMedicine. 2019.
• Wiesener A, et al. Molecular Diagnosis of Kidney Transplant Failure by the Urine. Am.J.Transplant. 2019.
• Ziemann M, et al. Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation: A Multicenter Study. Clin.J.Am.Soc.Nephrol. 2019.

Allgemein

• Figueiredo C, et al. Silencing of HLA class I on primary human hepatocytes as a novel strategy for reduction in alloreactivity. J Cell Mol Med. 2019.
• Melk A, et al. Equally Interchangeable? How Sex and Gender Affect Transplantation. Transplantation. 2019.
• Jaeckel E, et al. Tipping the Balance. Transplantation. 2019.
• Kamar N, et al. Hepatitis E Virus Ribavirin Study Group. Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study. Clin.Infect.Dis.. 2019.
• Ius F, et al. Cardiac valve operations after solid organ transplantation: A single-center experience. J.Thorac.Cardiovasc.Surg. 2019.
• Blöte R, et al. Greater Susceptibility for Metabolic Syndrome in Pediatric Solid Organ and Stem Cell Transplant Recipients. Transplantation. 2019.
• Webb N, et al. Pharmacokinetics of tacrolimus granules in pediatric de novo liver, kidney, and heart transplantation: The OPTION study. Pediatr.Transplant. 2019.
• Janssens E. Widerspruchslösung bei der Organspende? Eine Umfrage bei Mitgliedern der Deutschen Gesellschaft für internistische Intensivmedizin und Notfallmedizin. Med.Klin.Intensivmed.Notfmed. 2019.

Reviews

• Oedingen C, et al. Systematic Review of Public Preferences for the Allocation of Donor Organs for Transplantation: Principles of Distributive Justice. Review article. Patient. 2019.
• Mariani S, et al. Device profile of the heartware HVAD system as a bridge-to-transplantation in patients with advanced heart failure: overview of its safety and efficacy. Expert Rev.Med.Devices. 2019.
• Rojas SV, et al. Heart failure: ventricular assist devices and cardiac transplantation : A review of current surgical innovations. Review article Chirurg. 2019.
• Scurt FG, et al. Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysis. Lancet. 2019.
• Welte T, et al. Invasive mould infections in solid organ transplant patients: modifiers and indicators of disease and treatment response. Review article. Infection. 2019.

• Chatterjee A, et al. Clinical overview of the HVAD: a centrifugal continuous-flow ventricular assist device with magnetic and hydrodynamic bearings including lateral implantation strategies. J.Thorac.Dis. 2018.
• Chatterjee A, et al. The momentum of HeartMate 3: a novel active magnetically levitated centrifugal left ventricular assist device (LVAD). J.Thorac.Dis. 2018.
• Deniz E, et al. How to do it: tips and tricks of minimal-invasive HVAD((R)) implantation-the lateral approach. J.Thorac.Dis. 2018.
• Feldmann C, et al. An acoustic method for systematic ventricular assist device thrombus evaluation with a novel artificial thrombus model. J.Thorac.Dis. 2018.
• Gärtner T, et al. In vitro study for the evaluation of transluminal aspiration as a novel treatment option for thrombosis in the HeartWare HVAD. Int.J.Artif.Organs. 2018.
• Hanke JS, et al. Driving After Left Ventricular Assist Device Implantation. Artif.Organs. 2018.
• Hanke JS, et al. Five-year results of patients supported by HeartMate II: outcomes and adverse events. Eur.J.Cardiothorac.Surg. 2018.
• Hanke JS, et al. Left ventricular assist device exchange for the treatment of HeartMate II pump thrombosis. J.Thorac.Dis. 2018.
• Ricklefs M, et al. A new tool for an explantation strategy of HeartMate 3 left ventricular assist device. J.Thorac.Dis. 2018.
• Ricklefs M, et al. Less Invasive Surgical Approaches for Left Ventricular Assist Device Implantation. Semin.Thorac.Cardiovasc.Surg. 2018.
• Ricklefs M, et al. Successful HeartMate 3 implantation in isolated right heart failure-first in man experience of right heart configuration. J.Thorac.Dis. 2018.
• Rojas SV, et al. Left Ventricular Assist Device Therapy for Destination Therapy: Is Less Invasive Surgery a Safe Alternative? Rev.Esp.Cardiol.(Engl.Ed). 2018.
• Smits JM, et al. Heart re-transplantation in Eurotransplant. Transpl Int. 2018.
• Wert L, et al. Argatroban administration as therapy for thrombosis in patients with continuous-flow ventricular assist devices. J.Thorac.Dis. 2018.
• Wert L, et al. Minimally invasive surgery improves outcome of left ventricular assist device surgery in cardiogenic shock. J.Thorac.Dis. 2018.
• Wert L, et al. Reduction of driveline infections through doubled driveline tunneling of left ventricular assist devices-5-year follow-up. J.Thorac.Dis. 2018.
• Wert L, et al. Treatment of an Intercostal Left Ventricular Assist Device Prolapse by Upgrading From HeartMate II to HeartMate 3. Artif.Organs. 2018.

• Adam R, et al. 2018 Annual Report of the European Liver Transplant Registry (ELTR) - 50-year evolution of liver transplantation. Transpl Int. 2018.
• Baumann U, et al. Survival of children after liver transplantation for hepatocellular carcinoma. Liver Transpl. 2018.
• Berenguer M, et al. The road map toward an hepatitis C virus-free transplant population. Am J Transplant. 2018.
• Cammann S, et al. Early Tracheostomy Reduces Time of Mechanical Ventilation in Respiratory High-Risk Patients After Liver Transplant. Exp Clin Transplant. 2018.
• Filali Bouami S, et al. Prognostic factors for long-term survival after adult liver transplantation. Langenbecks Arch Surg. 2018.
• Getzin T, et al. Gd-EOB-DTPA-enhanced MRI for quantitative assessment of liver organ damage after partial hepatic ischaemia reperfusion injury: correlation with histology and serum biomarkers of liver cell injury. Eur Radiol. 2018.
• Goldschmidt I, et al. Immune monitoring after pediatric liver transplantation - the prospective ChilSFree cohort study. BMC Gastroenterol. 2018.
• Heits N, et al. Evolutionary Distance Predicts Recurrence After Liver Transplantation in Multifocal Hepatocellular Carcinoma. Transplantation. 2018.
• Herzer K, et al. Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in Germany. J Hepatol. 2018.
• Hueper K, et al. Assessment of liver ischemia reperfusion injury in mice using hepatic T2 mapping: Comparison with histopathology. J Magn Reson Imaging. 2018.
• Leiskau C, et al. Side effects and efficacy of renal sparing immunosuppression in pediatric liver transplantation-A single center matched cohort study. Pediatr Transplant. 2018.
• Lipinski M, et al. Clinical characteristics of patients with liver cirrhosis and spontaneous portosystemic shunts detected by ultrasound in a tertiary care and transplantation centre. Scand J Gastroenterol. 2018.
• Madadi-Sanjani O, et al. Long-term outcome and necessity of liver transplantation in infants with biliary atresia are independent of cytokine milieu in native liver and serum. Cytokine. 2018
• Pfister ED, et al. Predictive Factors for Survival in Children Receiving Liver Transplants for Wilson's Disease: A Cohort Study Using European Liver Transplant Registry Data. Liver Transpl. 2018.
• Pflugrad H, et al. Longterm calcineurin inhibitor therapy and brain function in patients after liver transplantation. Liver Transpl. 2018.
• Qu Z, et al. Evaluation of published assessment tools for comorbidity in liver transplantation: a systematic review protocol. BMJ Open. 2018.
• Qu Z, et al.  Hangzhou criteria are more accurate than Milan criteria in predicting long-term survival after liver transplantation for HCC in Germany. Langenbecks Arch Surg. 2018.
• Schrem H, et al. Statistical approach to quality assessment in liver transplantation. Langenbecks Arch Surg. 2018.
• Sommerer C, et al. Five-year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low-exposure cyclosporine versus standard therapy. Am J Transplant. 2018.
• Thude H, et al. The killer cell lectin-like receptor B1 (KLRB1) 503T>C polymorphism (rs1135816) and acute rejection after liver transplantation. HLA. 2018.

• Bobylev D, et al. Single lung transplantation from a donor 8 months after double lung transplantation. Am J Transplant. 2018.
• Dettmer S, et al. Lobe-wise assessment of lung volume and density distribution in lung transplant patients and value for early detection of bronchiolitis obliterans syndrome. Eur J Radiol. 2018.
• Drick N, et al. DNA-based testing in lung transplant recipients with suspected non-viral lower respiratory tract infection: A prospective observational study. Transpl Infect Dis. 2018.
• Drick N, et al. Self-reported non-adherence to immunosuppressive medication in adult lung transplant recipients-A single-center cross-sectional study. Clinical trial Clin Transplant. 2018.
• Ius F, et al. Extracorporeal membrane oxygenation as a bridge to lung transplantation may not impact overall mortality risk after transplantation: results from a 7-year single-centre experience. Eur J Cardiothorac Surg. 2018.
• Ius F, et al. Preemptive treatment of early donor-specific antibodies with IgA- and IgM-enriched intravenous human immunoglobulins in lung transplantation. Am J Transplant. 2018.
• Morlacchi LC, et al. The burden of sinus disease in cystic fibrosis lung transplant recipients. Transpl Infect Dis. 2018.
• Rademacher J, et al. Infection transmission among lung transplant couples. Transpl Infect Dis. 2018.
• Renne J, et al. Multiparametric MRI for organ quality assessment in a porcine Ex-Vivo lung perfusion system. PLoS One. 2018.
• Salman J, et al. Role for primary immunosuppression with everolimus after pulmonary transplantation. Transpl Immunol. 2018.
• Salman J, et al. The liver-first approach for combined lung and liver transplantation. Eur J Cardiothorac Surg. 2018.
• Sommer W, et al. Technique and Outcomes of Less Invasive Lung Retransplantation. Transplantation. 2018.
• Steinmeyer J, et al. Cellular and acellular ex vivo lung perfusion preserve functional lung ultrastructure in a large animal model: a stereological study. Respir Res. 2018.
• Warnecke G, et al. Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study. Randomized controlled trial. Lancet Respir Med. 2018.
• Zinne N, et al. Treatment of infected lungs by ex vivo perfusion with high dose antibiotics and autotransplantation: A pilot study in pigs. PLoS One. 2018.
• Zimmermann T, et al.  The Transplant Evaluation Rating Scale (TERS): A Tool for the Psychosocial Evaluation of Lung Transplant Candidates. Psychosom Med Psychother. 2018.

 

• Casper J, et al. Renal transplant recipients receiving loop diuretic therapy have increased urinary tract infection rate and altered medullary macrophage polarization marker expression. Kidney Int. 2018.
• Einecke G, et al. Fatal Pneumococcus Sepsis after Treatment of Late Antibody-Mediated Kidney Graft Rejection. Case Rep Nephrol. 2018.
• Eisenberger U, et al. Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study.Randomized controlled trial. BMC Nephrol. 2018.
• Greite R, et al. Renal ischemia-reperfusion injury causes hypertension and renal perfusion impairment in the CD1 mice which promotes progressive renal fibrosis. Am J Physiol Renal Physiol. 2018.
• Kleine-Döpke D, et al. Renal cell cancer after kidney transplantation. Langenbecks Arch Surg. 2018.
• Kölling M, et al. Hypoxia-induced long non-coding RNA Malat1 is dispensable for renal ischemia/reperfusion-injury. Sci Rep. 2018.
• Littbarski SA, et al. Timing of parathyroidectomy in kidney transplant candidates with secondary hyperparathryroidism: effect of pretransplant versus early or late post-transplant parathyroidectomy. Surgery. 2018.
• Peperhove M, et al. Assessment of acute kidney injury with T1 mapping MRI following solid organ transplantation. Eur Radiol. 2018.
• Schumann-Bischoff A, et al. Distinct morphological features of acute tubular injury in renal allografts correlate with clinical outcome. Am J Physiol Renal Physiol. 2018.
• Thorenz A, et al. Enhanced activation of interleukin-10, heme oxygenase-1, and AKT in C5aR2-deficient mice is associated with protection from ischemia reperfusion injury-induced inflammation and fibrosis. Kidney Int. 2018.
• Zorn KS, et al. Development and validation of a prognostic model for kidney function 1 year after combined pancreas and kidney transplantation using pre-transplant donor and recipient variables. Langenbecks Arch Surg. 2018.

Transplantation

• Peperhove M, et al. Assessment of acute kidney injury with T1 mapping MRI following solid organ transplantation. Eur Radiol. 2018.

Reviews

• Qu Z, et al. Decision modelling for economic evaluation of liver transplantation. Review article. World J Hepatol. 2018.
• Feldmann C, et al. Left Ventricular Assist Devices - A State of the Art Review. Adv.Exp.Med.Biol. 2018.